PD Dr. Benjamin Frey

Medizinische Fakultät Department of Radiation Oncology

DNA as the main target in radiotherapy—a historical overview from first isolation to anti-tumour immune response (2023) Frey B, Borgmann K, Jost T, Greve B, Oertel M, Micke O, Eckert F Journal article, Review article Editorial: Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer, and esophageal cancer, volume II (2023) Li Y, Wang Y, Gao J, Tan K, Frey B, Gaipl U, Shi H, Ma X Journal article Clonogenicity-based radioresistance determines the expression of immune suppressive immune checkpoint molecules after hypofractionated irradiation of MDA-MB-231 triple-negative breast cancer cells (2023) Gehre S, Meyer F, Sengedorj A, Grottker F, Reichardt C, Alomo J, Borgmann K, et al. Journal article Biocompatibility of Dextran-Coated 30 nm and 80 nm Sized SPIONs towards Monocytes, Dendritic Cells and Lymphocytes (2023) Zschiesche L, Janko C, Friedrich B, Frey B, Band J, Lyer S, Alexiou C, Unterweger H Journal article Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studies (2023) Weissmann T, Rückert M, Putz F, Donaubauer AJ, Hecht M, Schnellhardt S, Schubert P, et al. Journal article, Review article Individual Radiation Sensitivity and Biomarkers: Molecular Radiation Biology (2023) Ainsbury EA, Abrantes AM, Baatout S, Baeyens A, Botelho MF, Frey B, Foray N, et al. Authored book Detailed in vitro analyses of the impact of multimodal cancer therapy with hyperthermia and radiotherapy on the immune phenotype of human glioblastoma cells (2022) Stoll E, Hader M, Rückert M, Weissmann T, Lettmaier S, Putz F, Hecht M, et al. Journal article Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines (2022) Schatz J, Ladinig A, Fietkau R, Putz F, Gaipl U, Frey B, Derer A Journal article Orofacial clefts lead to increased pro-inflammatory cytokine levels on neonatal oral mucosa (2022) Seidel CL, Percivalle E, Tschaftari M, Weider M, Strobel K, Willershausen I, Unertl C, et al. Journal article Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy (2022) Hecht M, Eckstein M, Kallies A, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution, Abstract of a poster